On July 24, EFPIA and PhRMA formally launched their Joint Principles for Responsible Clinical Trial Data Sharing to Benefit Patients. This commitment to data sharing will enhance research and scientific knowledge, advance patient care and improve public health. Under the Principles, biopharmaceutical companies will dramatically increase the amount of information.
"The Disclosure Code has been approved by the General Assembly on 24 June 2013. The final edited versions of the Code has been submitted to Compliance Committee comments, and has been reviewed by legal counsel.
EFPIA 2013 Annual Meetings - EFPIA President Chris Viehbacher (Sanofi) outlines the priorities for the Pharmaceutical Industry.
EFPIA 2013 Annual Meetings - Fredrik Erixon, Director of the European Centre for International Political Economy (ECIPE)
Efpia 2013 Annual Meetings - Paul Krugman, Keynote Speaker Nobel Prize Economist
EFPIA 2013 Annual Meetings - Nicola Bedlington - European Patients Forum Executive Director